Incaptek

Incaptek

Private
CourrouxHealthcare & Life Scienceshttps://incaptek.com/

Last Round

Grant

May 21, 2024

Total Funding Raised

$11,000

Company Overview

Incaptek is a biotech and materials science company that develops advanced drug delivery systems and high-performance materials for various industries.

Sector

Healthcare & Life Sciences

Verticals

Advanced Materials, Biotechnology, Medical Devices

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

microencapsulationcontrolled release deliverydrug delivery systemsnanoencapsulationadvanced materialsdeep techtechnology licensingdrug-eluting coatingsmaterials sciencetargeted drug deliveryhigh performance materialsbiomaterialssmart materialscontract research organizationCROfunctional foodsnutraceuticalsaerospace materials

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Incaptek Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Incaptek Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
GrantMay 21, 2024
AcceleratorApr 26, 2024
AcceleratorAug 2, 2023
AcceleratorMar 2, 2023

Key People

Founding team and executive leadership

Olga Fontanellaz

CEO And Co-founder

Founding Team

Incaptek Investors

Notable investors and investment history

InvestorRounds
DayOneAccelerator
Plug and Play JapanAccelerator
Venture KickGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 8, 2025

    Monthly visitors grew 385% MoM, from 457 to 2.2K.

  • Oct 29, 2024

    Monthly visitors grew 194% MoM.

Incaptek Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Incaptek Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Incaptek's valuation, stock price, and market status.

Firmographic Details

HeadquartersCourroux
Employee Range2
Year Founded2022
Last FundingMay 21, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.